@xconomy.com 3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@slashgear.com 3 years ago
Gilead CEO answers big COVID-19 question: How much will remdesivir cost
@xconomy.com 4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com 5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@techcrunch.com 7 years ago
GlaxoSmithKline and Google’s life science wing form new bioelectronic medicine company
@venturebeat.com 9 years ago
How lean-startup ideology could save your life